THANK YOU FOR SUBSCRIBING
FREMONT, CA: A trendsetter of the healthcare industry, CyMedica Orthopedics launched the clinical trial of its established muscle strengthening equipment, e-vive, which also functions as a patient engagement system for knee osteoarthritis patients. The health data of the patient collected by the wearable smartwatch devices will be mingled with the muscle strengthening e-vive technology to evaluate the effectiveness of the innovation on the recovering patient osteoarthritis (OA) symptoms.
The clinical trial initiated will be implemented on around 120 osteoarthritis patients in medical collaboration with New York’s most extensive health system, Northwell Health. In the field of osteoarthritis knee pain treatment, the clinical trial of e-vive by CyMedica is a mark of innovative progression. The device is non-narcotic, harmless, and domestic-wearable, which will prove beneficial to millions of patients who undergo the painful continual struggle of knee arthritis.
The association of muscle weakness with knee osteoarthritis is one of the most frequent underlying clinical situation as well as for the patients improving from knee procedures with rehab challenges.
“The launch of the e-vive clinical trial for knee osteoarthritis is a significant step forward for CyMedica Orthopedics and represents our steadfast commitment to creating effective treatments for knee osteoarthritis patients. This clinical trial is specifically designed to measure the reduction of knee pain utilizing e-vive as a non-drug, non-invasive solution”, said Bryti Ketchum, Vice President of Marketing.
Elaborating on the current feedback, Bryti informed, “Following the recent positive results from the clinical trial conducted at Cleveland Clinic, e-vive continues to be proven as an effective solution for regaining quadriceps strength and function in total knee replacement patients. By pairing this positive data with the highest patient engagement levels of all app-driven medical devices, e-vive offers a transformative new approach to treatment for the growing joint disease population.”
CyMedica Orthopedics has come up with an innovative digital health combination technology platform, which is based on therapy and engages patients and encourages healthcare providers to take care of muscle pain caused by surgery or knee osteoarthritis. The app-based technology improves clinical outcomes while accumulating crucial data useful in measuring and promoting the patient’s progress. The ground-breaking digital wearable technology, e-vive, has cleared the strict FDA and provides muscle activation and patient engagement system exclusively built to deliver muscle stimulation therapy while connecting patients and healthcare providers in real-time distantly.